Neurosense Therapeutics Ltd. (NRSN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NeuroSense Therapeutics Ltd., an Israeli-based company, has announced the issuance and sale of ordinary shares through a Sales Agreement with JonesTrading Institutional Services LLC. The shares are to be offered pursuant to a registration statement and will be validly issued, fully paid, and non-assessable upon completion of certain corporate procedures. This move is part of the company’s efforts to increase its financial flexibility and continue its growth trajectory.
For further insights into NRSN stock, check out TipRanks’ Stock Analysis page.